Procos Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TROSPIUM CHLORIDE, with a corresponding US DMF Number 22079.
Remarkably, this DMF maintains an Active status since its submission on October 08, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 02, 2018, and payment made on December 15, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II